PKQuest: A general physiologically based pharmacokinetic model. Introduction and application to propranolol

David G. Levitt

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Background: A "physiologically based pharmacokinetic" (PBPK) approach uses a realistic model of the animal to describe the pharmacokinetics. Previous PBPKs have been designed for specific solutes, required specification of a large number of parameters and have not been designed for general use. Methods: This new PBPK program (PKQuest) includes a " Standardhuman" and "Standardrat" data set so that the user input is minimized. It has a simple user interface, graphical output and many new features: 1) An option that uses the measured plasma concentrations to solve for the time course of the gastrointestinal, intramuscular, intraperotineal or skin absorption and systemic availability of a drug - for a general non-linear system. 2) Capillary permeability limitation defined in terms of the permeability-surface area products. 4) Saturable plasma and tissue protein binding. 5) A lung model that includes perfusion-ventilation mismatch. 6) A general optimization routine using either a global (simulated annealing) or local (Powell) minimization applicable to all model parameters. Results: PKQuest was applied to measurements of human propranolol pharmacokinetics and intestinal absorption. A meal has two effects: 1) increases portal blood flow by 50%; and 2) decreases liver metabolism by 20%. There is a significant delay in the oval propranolol absorption in fasting subjects that is absent in fed subjects. The oral absorption of the long acting form of propranolol continues for a period of more than 24 hours. Conclusions: PKQuest provides a new general purpose, easy to use, freely distributed [] and physiologically rigorous PBPK software routine.

Original languageEnglish (US)
Article number5
JournalBMC Clinical Pharmacology
StatePublished - Aug 15 2002


Dive into the research topics of 'PKQuest: A general physiologically based pharmacokinetic model. Introduction and application to propranolol'. Together they form a unique fingerprint.

Cite this